Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.480
+0.010 (0.40%)
Mar 9, 2026, 2:44 PM EDT - Market open
Veru Inc. Employees
Veru Inc. had 20 employees as of September 30, 2025. The number of employees decreased by 190 or -90.48% compared to the previous year.
Employees
20
Change (1Y)
-190
Growth (1Y)
-90.48%
Revenue / Employee
n/a
Profits / Employee
-$955,676
Market Cap
39.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Xilio Therapeutics | 64 |
| Atara Biotherapeutics | 38 |
| Palatin Technologies | 29 |
| Jasper Therapeutics | 27 |
| Lisata Therapeutics | 26 |
| Actinium Pharmaceuticals | 25 |
| Atossa Therapeutics | 15 |
| CervoMed | 15 |
VERU News
- 6 hours ago - Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss - GlobeNewsWire
- 26 days ago - Veru Inc. (VERU) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th - GlobeNewsWire
- 2 months ago - Veru Inc. (VERU) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress - GlobeNewsWire
- 3 months ago - Veru to Report Fiscal Year 2025 Financial Results on December 17th - GlobeNewsWire
- 4 months ago - Veru to Present Two Abstracts at ObesityWeek 2025 - GlobeNewsWire
- 4 months ago - Veru Announces Proposed Public Offering - GlobeNewsWire